allodynia and semaglutide Understanding Allodynia: A Side Effect of GLP-1 Medications Skin reactions (allodynia) long term
Description
Conclusion Obesity is a highly prevalent condition that can be managed effectively using medications like Wegovy (Semaglutide)
Regular check-in protocols ensure ongoing patient safety
Semaglutide is typically started at 0.25 mg injected under the skin once per week for 4 weeks
Diabetic patients have reported experiencing worsening blood sugar spikes and higher blood sugar levels than before they started taking the drug
This visual check prevents confusion when managing multiple vial types
This means the first real therapeutic window opens around weeks four to five at your current dose
